Unstable Angina: Relationship of Clinical Presentation, Coronary Artery Pathology, and Clinical Outcome

Size: px
Start display at page:

Download "Unstable Angina: Relationship of Clinical Presentation, Coronary Artery Pathology, and Clinical Outcome"

Transcription

1 ~~~ ~ Clin. Cardiol. 16, (1993) Unstable Angina: Relationship of Clinical Presentation, Coronary Artery Pathology, and Clinical Outcome BARRY D. Bmm, M.D., JAY DINERMAN, M.D., RALP HARTKE, JR., M.D., C. Rlcw CONTI, M.D., F.A.C.C. Division of Cardiology, Department of Medicine, University of Florida College of Medicine, and the Veterans Administration Medical Center, Gainesville, Florida, USA Summary: Patients with unstable angina are heterogeneous with respect to presentation, coronary artery morphology, and clinical outcome. Subclassification of these patients based on clinical history has been proposed as a means of identifying individuals at increased cardiac risk. We applied such a classification system to 129 patients discharged from a coronary care unit with a diagnosis of acute myocardial ischemia. Patients were then assessed for cardiac events (recurrent angina requiring revascularization, myocardial infarction, death) 12 months following hospital discharge. Patients were classified as recent onset unstable angina preinfarction (n = 42), crescendo unstable angina preinfarction (n = 4), and unstable angina postinfarction (n = 39). Within each of these groups, the patients were further subclassified based on the occurrence of angina on effort, at rest, or both. No attempt was made to subset patients taking anti-ischemic drugs at the time of clinical presentation to the physician. Coronary angiographic pathology (morphology and number of vessels involved) was similar in the subgroups, but coronary artery thrombus was statistically more likely to be found in patients with crescendo rest angina preinfarction or with frequent anginal episodes at rest postinfarction. Mortality was significantly higher for patients with unstable angina postinfarction (7.7%) than preinfarction (1.1 %). No statistical differences were noted between the subgroups with respect to the occurrence of myocardial infarction or recurrent unstable angina requiring revascularization. These data suggest that subclassification of unstable angina patients based on clinical Reviews for this paper and the editorial decision to accept it were made by an editor other than Dr. Conti. Address for reprints: Barry D. Bertolet, M.D. Division of Cardiology Department of Medicine BOX J. Hillis Miller Health Center Gainesville, FL 32610, USA Received: October 15, 1992 Accepted with revision: December 16, 1992 characteristics at presentation is not useful to predict subsequent myocardial infarction or recurrent angina requiring revascularization. However, as one might expect, patients with recurrent angina postinfarction have a higher mortality rate than patients with unstable angina preinfarction, and patients with recurrent rest angina, either pre- or postinfarction, are more liely to have intracoronary thrombus than patients with new onset angina or crescendo effort angina; however, the presence of thrombus did not predict a poor clinical outcome. Key words: unstable angina, classification, coronary morphology, coronary artery disease, coronary thrombus Introduction Patients with unstable angina are a nonhomogeneous group of individuals. There are some data suggesting that subclassification based on clinical presentations has varied the risks for future cardiac events. Two such subgroup classification systems have been reported,'-* yet no one has related them to prognosis in a retrospective or prospective fashion. Any classification protocol is useful only if it provides prognostic information or identifies patients early on who require specific diagnostic studies or therapy in order to modify their condition. This report applies one subgroup classification system (Table I) in a retrospective fashion to all patients discharged from the coronary care unit (CCU) with the diagnosis of unstable angina who had angiopdphically proven coronary artery disease or documented myocardial ischemia.' Each patient was then observed over a 12-month period for any adverse cardiac events such as death, myocardial infarction, or recurrent unstable angina requiring revascularization. Materials and Methods Study Population The study population consisted of 129 consecutive patients discharged from the coronary care units at Shands Hospital at the University of Florida and the Gainesville VAMC from

2 B. D. Bertolet et al.: Clinical presentation, coronary artery pathology, and clinical outcome in unstable angina 7 TABLE I Clinical classification of unstable angina patients pteinfarctiona (no recent MI) Recent onset chest discomfod Effort and rest Crescendo chest discomfoltc Effort and rest Postinfarctiond (recent MI) Occasional chest discomfort' Frequent chest discomfortf a Patients admitted to CCU because of acute myocardial ischemia, not infarction. b Symptoms present for less than 1 month. Symptoms occuning more frequently, longer in duration, or with less exertion than in previous month. Patients admitted to CCU with acute myocardial infarction who have angina prior to discharge. One to two episodedday. /Three or more episodedday. January 1, 19, through December 31, 19. All 90 preinfarction patients were admitted to the CCU with chest pain suspicious for acute myocardial ischemia. After 24 hours none had enzyme or ECG evidence of myocardial infarction. The 39 postinfarction patients developed recurrent angina despite an initial stabilization of symptoms with medical therapy. There was no standard diagnostic or therapeutic protocol, but rather, a therapeutic strategy developed for the individual patient was utilized. At discharge from the CCU, the diagnosis of unstable angina was made based on the clinical history and documented evidence of ischemic heart disease. All patients had coronary artery disease proven at coronary angiography, or by ECG evidence of a previous myocardial infarction, ST-segment depression during pain or during exercise testing, or by radionuclide studies in a few instances. Coronary angiography was performed within 10 days of admission to hospital. Data Collection In addition to clinical presentation, cardiac risk factors and prescribed antiangina medications were recorded. Hypeension was defined as a diastolic blood pressure 2 90 mmhg, or a history of hypertension with concomitant use of antihypertensive medications. Hypercholesterolemia was defined as a total cholesterol mg/dl, or history of elevated cholesterol treated with diet or drugs. Diabetes was considered present when the fasting blood glucose was mg/dl, or if the patient was using hypoglycemic agents. Initial standard 12-lead ECGs were also evaluated for ST-T changes suggestive of myocardial ischemia, as well as left ventricular hypertrophy (LVH). ECG changes considered compatible with ischemia were transient ST-segment elevation or depression 2 1 mm 0 ms after the J point, or transient T-wave flattening or inversion. ECG changes compatible with LVH were defined as the S-wave voltage (mm) from leads VI or V2 plus R-wave voltage (mm) from leads V5 Or v mm. Coronary angiograms were assessed for coronary artery stenosis and morphology by two cardiologists. A 50% stenosis of the left main coronary artery or a 70% stenosis of any other coronary arteries was consided sigmticant. Coronary artery morphology classification is shown in Table II. Drug therapy for preinfarction and postinfarction unstable angina in the coronary care unit consisted of thrombolytic agents, 0 (0%); beta-blockers, 49 (3%); heparin, 79 (61%); calcium antagonists, 91 (71%); aspirin, 1 (6%); nitrates, 127 (9%). The frequency of use of any of the above drug pups was similar between the unstable angina patients preinfarction and postinfarction. Recorded Cardiac Events The status of patients was assessed for cardiac events for 1 year following discharge utilizing the medical record andor telephone contact. Follow-up data were obtained in 126 of the 129 patients by one or both methods. Recorded cardiac events were recurrent unstable angina pectoris requiring revascularization, myocardial infarction, and death. TABLE II Classification of coronary artery morphology (3) Morphology type A B B2 C Lesion characteristics Discrete Less than 1 cm in length Noncalcified Bend < 45 ' Presence of one of the following descriptions: 1-2 cm in length Calcified Eccentric Ulcerated or irregular Bend 2 45" and <60" Recent occlusion Presence of two or more of the descriptions in B Greater than 2 cm in length Extremely calcified Extremely irregular Bend 2 60" Chronic occlusion

3 Clin. Cardiol. Vol. 16, February 1993 Data Analysis For comparison between the subgroups, statistical analysis is based on analysis of variance (ANOVA) followed by paired t-tests. All values are expressed as mean f standard error. Differences between group means are considered significant at p< ReSUltS Patient Demographics and CliNad Presentation Patient demographics and clinical presentation are summarized in Table III. The clinical presentation of the 90 unstable angina patients preinfarction and 39 postinfarction was varied, as one might expect, and the data are summarized in Table IV. Of the preinfarction patients with recent onset unstable angina, 14 of 42 (33%) were receiving antiangina drugs at admission. These drugs, that is, beta blockers or calcium antagonists, were prescribed for nonischemic conditions such as hypertension. Of the preinfarction patients with crescendo unstable angina, 42 of 4 (7.5%) were receiving antiangina medications at the time of admission. Of the postinfarction patients, 36 of 39 (92.3%) were receiving antiangina medication at the time of develop ment of their recurrent angina. Thus, antiangina drugs were used more commonly (as one might expect) in patients with crescendo and postinfarction angina than in patients with recent onset angina. Electrocardiography during Chest Pain ECG abnormalities suggestive of myocardial ischemia were noted in 53% of the initial ECGs obtained. The distribution of abnormal ECGs for each subgroup is shown in Table V. There was no difference among the various subgroups. Coronary Artery Pathology (Morphology) Coronary angiography was performed in 101 of 129 (7%) of the study population. Table VI summarizes these results. Left main coronary artery stenosis was identified in 13 of 101 (1 3%) patients studied by angiography. Multivessel disease was present in 50 of 101 (50%). and single-vessel disease was observed in 3 of 101 (3%). The frequency and distribution of CAD was similar among the groups, yet there was a trend (p = 0.15) toward more multivessel disease in the mscendo unstable angina and unstable angina postinfarction groups than in the recent onset unstable angina group. The morphology of the diseased coronary arteries was classified as in Table II. Table W summarizes the coronary morphology arranged according to the unstable angina groups. The angiographic appearance of coronary thrombus was noted in 1 of 101 (1%) patients, but was identified only in patients with crescendo unstable angina pre- or postinfarction occurring at rest. TABLE In Demographics of unstable angina patients and clinical presentation Preinfarction Postinfarction Clinical Recent onset Crescendo Recurrent feature angina (n = 42) angina (n = 4) angina (n = 39) Age (mean) 37- (5.4) 3-1 (60.) 46-7 (61.6) Male 30 (73%) 32 (67%) 35 (90%) Female 12 (29%) 16 (33%) 4(10%) Hypertension 22 (52%) 25 (52%) 15 (39%) Elevated cholesterol 10 (24%) 16 (33%) 7(1%) Diabetes (19%) I3 (27%) 12(31%) Smoking 32 (76%) 25 (52%) 21 (54%) Fn CAD 19 (45%) 23 (4%) 19 (49%) LVH (ECG) 3 (7%) 6(13%) 2 (5%) Abbreviations: FH CAD = family history of coronary artery disease, LVH = left ventricular hypertrophy. TABLE IV Clinical presentation of unstable angina Preinfarction (90 patients) Recent onset (42 patients) Effo~t angina Effort and rest angina Rest angina Crescendo (4 patients) % Effort angina Effort and rest angina Rest angina Postinfarction (39 patients) Effort angina: frequent (3 or more) episodedday Rest angina: occasional (1-2) episodedday Rest angina: frequent (3 or more) episodedday Cardiac Events % I Over a 12-month period after initial discharge from the CCU, 44 cardiac events occurred in 35 of the 129 patients. The majority of these events occurred within the first 6 months (W44, 77%). These results are summarized in Table VIII. Mortalily: Four of the 129 patients died (3.1 %). Of these patients, three had ischemic changes on the admission ECG; all had rest pain. No deaths occurred within the 1 -month period after admission, but three occurred within the first 6 months. Three underwent coronary angiography-one had left main disease and two had 2-vessel CAD. The coronary artery morphology was type B (Table n) with associated thrombus in each case. The difference in mortality between unstable angina patients preinfarction, ( 1/90, l. l %), compared with unstable angina patients postinfarction (3/39,7.7%) was statistically significant (p < 0.05). Myocardial infarction: Of the 129 patients, 16 (12.4%) evolved a myocardial infarction; of these (69%) had is-

4 B. D. Bertolet et al.: Clinical presentation, coronary artery pathology, and clinical outcome in unstable angina 9 TABLE V Initial ECG among unstable angina subgroups Clinical presentation Patients - ST-T Changes + ST-T Changes Preinfarction Recent onset angina Effort Effodrest 4 7 Rest Subtotal Crescendo angina Effo~t Effodrest Rest Subtotal POs!irifmtion angina Occasional rest Frequent effort Frequent rest Subtotal Total ~~ ST-T change, ST-segment elevation or depression and/or 10" T-wave axis shift from baseline suggestive of myocardial ischemia. chemic changes on the initial ECG. Four of the MIS occurred within the first 4 weeks after discharge, with 12 of 16 taking place within 6 months after discharge. Coronary angiography revealed an equal distribution of stenotic coronary vessels; three patients had angiographic evidence of coronary thrombosis. Coronary morphology demonstrated two type A, three type B, nine type B2, and one type C lesions. No difference was noted between the two unstable angina preinfmtion groups, recent onset (7/42, 17%), and crescendo (6/4, 12.5%), nor between those with effort-induced unstable angina (3/24,12.5%) and unstable angina at rest (1 3/105,12.4%), nor between those with unstable angina preinfarction (13/90,14.4%) and postinfarction (3/39,7.7%). Recurrent unstable angina requiring revascularization: Of the 129 patients, 24 (1.6%) developed recurrent unstable angina requiring revascularization and of these (40%) had ischemic changes on the initial admission ECG. Recurrent angina within the first month following dischge occurred in three pa- TABLE VI Coronary artery pathology among unstable angina subgroups clinical Number with presentation Patients angiogram Lh4 CAD 3-v CAD 2-v CAD I-VCAD Preinfatrtion Recent onset angina Effort Effodrest Rest Subtotal Crescendo angina Effort Effodrest Rest Subtotal Postinfarction Angina Occasional rest Frequent effort Frequent rest Subtotal Total Abbreviations: LM = left main, CAD = coronary artery disease.

5 120 Clin. Cardiol. Vol. 16, February 1993 TABLE VU Coronary morphology type among unstable angina groups Clinical Angiography Morphology type (%) presentation Patients (n) A B 2 C Thrombus Preinfarction unstable angina Recent onset (23) 4() I (51) 5 (14) 0 Crescendo (15) (2) 1 (45) 5 (13) 7 Postinfarction Recurrent angina () 17 (65) 6 (23) l(4) II Total I6 (16) 32 (32) 42 (42) II () 1 TABLE VUI Cardiac events occurring during a 12-month period related to general clinical presentation ( 129 patients) Recent onset Crescendo preinfarction preinfmtion Postinfarction (n = 42) (n = 4) (n = 39) Event Time span Death MI RARR Death MI RARR Death MI RARR total <I months - I months months I 7-12 months I Total number 0 7 II (%I (0) (17) (26) (2) (13) (17) () () (13) Abbreviations: MI = myocardial infarction, RARR = recurrent angina requiring revascularization. tients, with 19 of 24 events occurring within the fmt 6 months of follow-up. The extent of coronary artery pathology was varied. However, no statistical differences were noted either between patients with unstable angina preinfarction ( 19/90,21 %) and those with unstable angina postinfatdon (5/39,13%), or between patientswithunstableanginaatrest(20/105,19%)andthosewith effort-induced unstable angina (4/24,17%), or between the two subclassifications of preinfmtion unstable angina. Ninety-four patients (73%) had no defined cardiac event in the 1 -year follow-up; however, 19 of these patients (20%) did have recurrent angina which was treated successfully by further aggressive medical therapy. Determination of Risk Cardiac events could not be predicted based on age, sex, cardiac risk factors, admission ECG, coronary anatomy, and coronary artery morphology (Tables IX and X). No difference could be found in the number of cardiac risk factors present in patients who ultimately had a cardiac event (2.2) and those who did not (2.0). Similarly, ischemic changes on the initial admission ECG did not identify those at risk for future events. Of the 35 patients who had a cardiac event, 19 (54%) had initial ECG changes suggestive of ischemia, compared with 49 of 94 (52%) patients with no event. Neither the extent of the coronary artery disease nor coronary artery morphology could project future cardiac events. The positive predictive value for each category evaluated was less than 50%. The diagnosis of coronary throm- bus at angiography was made in 1 of 60 (30%) patients with either crescendo unstable angina occurring at rest preinfmtion or frequent unstable angina occurring at rest postinfarction. No thrombus was noted at the time of coronary angiography in the other unstable angina groups. This difference attained statistical significance (p ~0.001). However, evidence of coronary thrombosis did not predict adverse cardiac risk. Discussion In this analysis, a detailed clinical classification protocol of unstable angina was used in 129 hospitalized patients over a TABLE IX Cardiac event rate occuning during a 12-month period related to age, sex, ECG changes, and risk factors Cardiac event No cardiac event Total n = 35 (27%) n = 94 (63%) n = 129 (%) Age (mean) 3-2 (59.2) 37- (60.7) 37- (60.3) Male (%) 2 (0) 69 (73) 97 (75) Ischemic changes on initial ECG 19 (56) 49 (52) 6 (53) Mean number cardiac risk factors

6 B. D. Bertolet et al.: Clinical presentation, coronary artery pathology, and clinical outcome in unstable angina 121 TABLE X PhologY Cardiac event rate occurring during a 12 month period related to coronary angiographic disease severity and coronary artery mor- Coronary artery pathology Anatomy Angiograms Left main 3-v CAD 2-v CAD 1-v CAD Morphology A B B2 C Angiographic coronary artery thrombus Cardiac events No cardiac events Total Patients Death MI RAW Patients patients Abbreviations: MI = myocardial infarction, RARR = recurrent unstable angina requiring revascularization, CAD = coronary artery disease Zmonth period following discharge from the hospital in an attempt to identify risk for future cardiac events. Cardiac risk factors were present in a majority of these patients; however, neither their presence nor number correlated with futw events. ECG changes suggestive of ischemia noted on admission were not predictive of cardiac events. However, a majority of patients who died (3/4) or evolved a myocardial infarction (1 1/16) had ischemic ECG changes at admission. Coronary angiographic pathology was similar among the clinical subgroups. The distribution of CAD in this study was similar to that noted by Plotnick et al4 in 190 in their angiographic studies of unstable angina patients, that is, there was a trend toward more multivessel disease in the crescendo unstable angina p up compared with the recent onset angina group. There was, however, no relationship between coronary artery stenosis or the number of stenotic vessels and future cardiac events. The majority of patients had complex coronary artery morphology (type B or C); however, the positive predictive value of morphology on future cardiac events was poor. Bugiardini and associates? in unstable angina patients, found that the coronary morphology had a positive predictive value of only 55% in identtfying patients with unfavorable clinical outcomes. In a preliminary report, Hernandez et al6 using the Braunwald classification of unstable angina pectoris, tried to correlate clinical presentation with coronary artery pathology in 6 patients. There were 15 patients in Class I (new onset of severe angina or accelerated angina, no rest pain); 15 in Class II (angi- M at rest within the past month but not within the preceding 4 h); and 3 in Class IU (angina at rest within 4 h). There were no differences in the clinical variables among the groups. Ischemic ECG changes were recognized in 5%. There was a trend for more three-vessel CAD among Class I patients. Left main coronary artery disease was noted in five patients (7%), all Class III. Otherwise, the distribution of coronary pathology among the subclasses was without significant differences. These investigators concluded that Braunwald s classification does not allow prediction of coronary anatomy. The abstract contained no information concerning cardiac events. Conclusion This study yielded the following results: The classification scheme used identified subgroups of unstable angina patients likely to have coronary thrombus on angiography (rest angina); however, the presence of thrombus did not predict a poor clinical outcome. Mortality was signfxantly higher in unstable angina patients postinfarction (7.7%) compared with unstable angina patients preinfarction ( 1.1 %). Certain groups of patients, [i.e., those with no ischemic ECG changes at admission (47%) or those with recent onset unstable angina], considered by many to represent low risk, were just as likely to have cardiac events as other subgroups. Subclassification of unstable angina patients was not useful in predicting myocardial infarction or recurrent angina requiring revascularization. Overall, these patients, with medical intervention, have a low 1-year mortality (3%), but a high incidence of myocardial infarction (12%) and recurrent unstable angina requiring revascularization (19%). Seventy-seven percent of these events occurred in the 6-month period following discharge from the CCU. One may speculate that these cardiac events occurred in those patients with persistent unrecognized (silent) myocardial

7 122 Clin. Cardiol. Vol. 16, February 1993 ischemia. Perhaps identification and quantification of persistent myocardial ischemia might identify those patients who are at high risk for future cardiac events. References 1. Conti CR Editor's Note. Clin Cutriiol (199) 2. Braunwald E: Unstable angina: A classification. Circulutiori 0, (199) 3. Ryan TJ, Faxon DP, Gunnar RM, Kennedy JW, King ITI SB, Loop FD, Peterson KL, Reeves TJ, Williams DO, Winters WL, Fisch C, DeSanctis RW, Dodge HT, Weinberg SL: Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am C d Cudid 12, (I 9) Plotnick G, Fisher ML, Carliner NH, Becker LC: Cardiac catheterization in patients with unstable angina. J Am Med Assoc 244, ( 190) Bugiardini R, Pozzati A, Borghi A. Morgagni GL, Ottani F, Muzi A, Pudda P: Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome. Am J Curdiol67.46CkW ( I99 1) Hernandez MV, Escobar E, Florenzano F, Marin P Unstable angi- M: Angiographic correlation of Bmunwalds classification. Abstracts of the XIV Interumericun Congress of Cudiology No. 33,9 (1992)

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA

Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case Study 50 YEAR OLD MALE WITH UNSTABLE ANGINA Case History A 50-year-old man with type 1 diabetes mellitus and hypertension presents after experiencing 1 hour of midsternal chest pain that began after

More information

Treatment of ischaemic heart disease

Treatment of ischaemic heart disease European Heart Journal (1997) 18 {Supplement B), B11-B15 Treatment of ischaemic heart disease Role of drugs, surgery and angioplasty in unstable angina patients C. R. Conti Department of Medicine and Cardiology,

More information

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply.

WHI Form Report of Cardiovascular Outcome Ver (For items 1-11, each question specifies mark one or mark all that apply. WHI Form - Report of Cardiovascular Outcome Ver. 6. COMMENTS To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: OMB# 095-044 Exp: 4/06 -Affix label here- Clinical Center/ID:

More information

Acute Coronary Syndrome

Acute Coronary Syndrome ACUTE CORONOARY SYNDROME, ANGINA & ACUTE MYOCARDIAL INFARCTION Administrative Consultant Service 3/17 Acute Coronary Syndrome Acute Coronary Syndrome has evolved as a useful operational term to refer to

More information

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM

HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM REVIEW DATE REVIEWER'S ID HEART AND SOUL STUDY OUTCOME EVENT - MORBIDITY REVIEW FORM : DISCHARGE DATE: RECORDS FROM: Hospitalization ER Please check all that may apply: Myocardial Infarction Pages 2, 3,

More information

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases

Cardiovascular Disorders Lecture 3 Coronar Artery Diseases Cardiovascular Disorders Lecture 3 Coronar Artery Diseases By Prof. El Sayed Abdel Fattah Eid Lecturer of Internal Medicine Delta University Coronary Heart Diseases It is the leading cause of death in

More information

APPENDIX F: CASE REPORT FORM

APPENDIX F: CASE REPORT FORM APPENDIX F: CASE REPORT FORM Instruction: Complete this form to notify all ACS admissions at your centre to National Cardiovascular Disease Registry. Where check boxes are provided, check ( ) one or more

More information

Initial Medical and Surgical Management of Unstable Angina Pectoris

Initial Medical and Surgical Management of Unstable Angina Pectoris Clin. Cardiol. 2. 311-316 (I979) G. Witzstrock Publishing House. Inc. Editorial Initial Medical and Surgical Management of Unstable Angina Pectoris Introduction The purpose of this report is to review

More information

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 5, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 5, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)00546-5 CLINICAL

More information

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI

Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist. Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Medical Management of Acute Coronary Syndrome: The roles of a noncardiologist physician Norbert Lingling D. Uy, MD Professor of Medicine UERMMMCI Outcome objectives of the discussion: At the end of the

More information

12 Lead EKG Chapter 4 Worksheet

12 Lead EKG Chapter 4 Worksheet Match the following using the word bank. 1. A form of arteriosclerosis in which the thickening and hardening of the vessels walls are caused by an accumulation of fatty deposits in the innermost lining

More information

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION

OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION OUTCOME OF THROMBOLYTIC AND NON- THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL INFARCTION FEROZ MEMON*, LIAQUAT CHEEMA**, NAND LAL RATHI***, RAJ KUMAR***, NAZIR AHMED MEMON**** OBJECTIVE: To compare morbidity,

More information

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD

Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Safety of Single- Versus Multi-vessel Angioplasty for Patients with AMI and Multi-vessel CAD Mun K. Hong, MD Associate Professor of Medicine Director, Cardiovascular Intervention and Research Weill Cornell

More information

Belinda Green, Cardiologist, SDHB, 2016

Belinda Green, Cardiologist, SDHB, 2016 Acute Coronary syndromes All STEMI ALL Non STEMI Unstable angina Belinda Green, Cardiologist, SDHB, 2016 Thrombus in proximal LAD Underlying pathophysiology Be very afraid for your patient Wellens

More information

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study

Influence of Planned Six-Month Follow-Up Angiography on Late Outcome After Percutaneous Coronary Intervention A Randomized Study Journal of the American College of Cardiology Vol. 38, No. 4, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(01)01476-0 Influence

More information

A COMPARISON OF CORONARY ANGIOGRAPHY RESULTS IN PATIENTS WITH STABLE AND UNSTABLE ANGINA PECTORIS

A COMPARISON OF CORONARY ANGIOGRAPHY RESULTS IN PATIENTS WITH STABLE AND UNSTABLE ANGINA PECTORIS Medical lournal of the Islamic Republic of Iran Volwne 11 Number 3 Fall 1376 November 1997 A COMPARISON OF CORONARY ANGIOGRAPHY RESULTS IN PATIENTS WITH STABLE AND UNSTABLE ANGINA PECTORIS S. H. AREFI,

More information

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease

Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Impact of coronary atherosclerotic burden on clinical presentation and prognosis of patients with coronary artery disease Gjin Ndrepepa, Tomohisa Tada, Massimiliano Fusaro, Lamin King, Martin Hadamitzky,

More information

Diagnostic and Prognostic Value of Holter-Detected ST-Segment Deviation in Unselected Patients With Chest Pain Referred for Coronary Angiography*

Diagnostic and Prognostic Value of Holter-Detected ST-Segment Deviation in Unselected Patients With Chest Pain Referred for Coronary Angiography* Diagnostic and Prognostic Value of Holter-Detected ST-Segment Deviation in Unselected Patients With Chest Pain Referred for Coronary Angiography* A Long-term Follow-up Analysis Chandra K. Nair, MD, FCCP;

More information

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis.

Type of intervention Diagnosis. Economic study type Cost-effectiveness analysis. The utility and potential cost-effectiveness of stress myocardial perfusion thallium SPECT imaging in hospitalized patients with chest pain and normal or non-diagnostic electrocardiogram Ben-Gal T, Zafrir

More information

What do the guidelines say?

What do the guidelines say? Percutaneous coronary intervention in 3-vessel disease and main stem What do the guidelines say? Nothing to disclose Dariusz Dudek Institute of Cardiology, Jagiellonian University Krakow, Poland The European

More information

Exercise-Induced Silent Ischemia: Age, Diabetes Mellitus, Previous Myocardial Infarction and Prognosis

Exercise-Induced Silent Ischemia: Age, Diabetes Mellitus, Previous Myocardial Infarction and Prognosis JACC Vol. 14, No. 5 November I. 1989:117.1-X0 1175 Exercise-Induced Silent Ischemia: Age, Diabetes Mellitus, Previous Myocardial Infarction and Prognosis PETER R. CALLAHAM, MD, VICTOR F. FROELICHER, MD,

More information

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Cronicon OPEN ACCESS CARDIOLOGY Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)? Valentin Hristov* Department of Cardiology, Specialized

More information

Chest Pain. Dr Robert Huggett Consultant Cardiologist

Chest Pain. Dr Robert Huggett Consultant Cardiologist Chest Pain Dr Robert Huggett Consultant Cardiologist Outline Diagnosis of cardiac chest pain 2016 NICE update on stable chest pain Assessment of unstable chest pain/acs and MI definition Scope of the

More information

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA

CLINICIAN INTERVIEW RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE. An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA RECOGNIZING ACS AND STRATIFYING RISK IN PRIMARY CARE An interview with A. Michael Lincoff, MD, and Eric R. Bates, MD, FACC, FAHA Dr Lincoff is an interventional cardiologist and the Vice Chairman for Research

More information

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014

Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications of Coronary Angiography Dr. Shaheer K. George, M.D Faculty of Medicine, Mansoura University 2014 Indications for cardiac catheterization Before a decision to perform an invasive procedure such

More information

Ischaemic heart disease. IInd Chair and Clinic of Cardiology

Ischaemic heart disease. IInd Chair and Clinic of Cardiology Ischaemic heart disease IInd Chair and Clinic of Cardiology Definition Syndrome due to chronic insufficient oxygen supply to myocardial cells Nomenclature: ischaemic heart disease (IHD), coronary artery

More information

My Patient Needs a Stress Test

My Patient Needs a Stress Test My Patient Needs a Stress Test Amy S. Burhanna,, MD, FACC Coastal Cardiology Cape May Court House, New Jersey Absolute and relative contraindications to exercise testing Absolute Acute myocardial infarction

More information

Results of Ischemic Heart Disease

Results of Ischemic Heart Disease Ischemic Heart Disease: Angina and Myocardial Infarction Ischemic heart disease; syndromes causing an imbalance between myocardial oxygen demand and supply (inadequate myocardial blood flow) related to

More information

Supplementary Material to Mayer et al. A comparative cohort study on personalised

Supplementary Material to Mayer et al. A comparative cohort study on personalised Suppl. Table : Baseline characteristics of the patients. Characteristic Modified cohort Non-modified cohort P value (n=00) Age years 68. ±. 69.5 ±. 0. Female sex no. (%) 60 (0.0) 88 (.7) 0.0 Body Mass

More information

Acute Coronary Syndromes

Acute Coronary Syndromes Overview Acute Coronary Syndromes Rabeea Aboufakher, MD, FACC, FSCAI Section Chief of Cardiology Altru Health System Grand Forks, ND Epidemiology Pathophysiology Clinical features and diagnosis STEMI management

More information

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why?

Screening for Asymptomatic Coronary Artery Disease: When, How, and Why? Screening for Asymptomatic Coronary Artery Disease: When, How, and Why? Joseph S. Terlato, MD FACC Clinical Assistant Professor, Brown Medical School Coastal Medical Definition The presence of objective

More information

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina

Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Medicine Dr. Omed Lecture 2 Stable and Unstable Angina Risk stratification in stable angina. High Risk; *post infarct angina, *poor effort tolerance, *ischemia at low workload, *left main or three vessel

More information

Coronary Artery Disease: Revascularization (Teacher s Guide)

Coronary Artery Disease: Revascularization (Teacher s Guide) Stephanie Chan, M.D. Updated 3/15/13 2008-2013, SCVMC (40 minutes) I. Objectives Coronary Artery Disease: Revascularization (Teacher s Guide) To review the evidence on whether percutaneous coronary intervention

More information

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia

Severe Coronary Vasospasm Complicated with Ventricular Tachycardia Severe Coronary Vasospasm Complicated with Ventricular Tachycardia Göksel Acar, Serdar Fidan, Servet İzci and Anıl Avcı Kartal Koşuyolu High Specialty Education and Research Hospital, Cardiology Department,

More information

Non-Invasive Evaluation of Coronary Vasospasm Using a Combined Hyperventilation and Cold-Pressure-Test Perfusion CMR Protocol

Non-Invasive Evaluation of Coronary Vasospasm Using a Combined Hyperventilation and Cold-Pressure-Test Perfusion CMR Protocol Journal of Cardiovascular Magnetic Resonance (2007) 9, 759 764 Copyright c 2007 Informa Healthcare USA, Inc. ISSN: 1097-6647 print / 1532-429X online DOI: 10.1080/10976640701544662 Non-Invasive Evaluation

More information

Background. After PCI for MI, angina has important implications on quality of life and healthcare utilization

Background. After PCI for MI, angina has important implications on quality of life and healthcare utilization Angina Prevalence and Management for Myocardial Infarction Patients Treated with Percutaneous Coronary Intervention: Insights from the TRANSLATE-ACS Study Alexander C. Fanaroff, Lisa A. Kaltenbach, Eric

More information

Practitioner Education Course

Practitioner Education Course 2015 Practitioner Education Course ST Elevation Myocardial Infarction 2 Pathology Concept of vulnerable plaque Mild Atheroma Diagnosis IVUS OCT 3 Diagnosis This is based on : Clinical History ECG Changes.

More information

The PAIN Pathway for the Management of Acute Coronary Syndrome

The PAIN Pathway for the Management of Acute Coronary Syndrome 2 The PAIN Pathway for the Management of Acute Coronary Syndrome Eyal Herzog, Emad Aziz, and Mun K. Hong Acute coronary syndrome (ACS) subsumes a spectrum of clinical entities, ranging from unstable angina

More information

DUKECATHR Dataset Dictionary

DUKECATHR Dataset Dictionary DUKECATHR Dataset Dictionary Version of DUKECATH dataset for educational use that has been modified to be unsuitable for clinical research or publication (Created Date and Time: 28OCT16 14:35) Table of

More information

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική ΕΛΛΗΝΙΚΗΚΑΡΔΙΟΛΟΓΙΚΗΕΤΑΙΡΕΙΑ Σεμινάριο Ομάδων Εργασίας 2011 Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική GUIDELINES ON MYOCARDIAL

More information

Pearls & Pitfalls in nuclear cardiology

Pearls & Pitfalls in nuclear cardiology Pearls & Pitfalls in nuclear cardiology Maythinee Chantadisai, MD., NM physician Division of Nuclear Medicine, Department of radiology, KCMH Principle of myocardial perfusion imaging (MPI) Radiotracer

More information

Acute Myocardial Infarction

Acute Myocardial Infarction Acute Myocardial Infarction Hafeza Shaikh, DO, FACC, RPVI Lourdes Cardiology Services Asst.Program Director, Cardiology Fellowship Associate Professor, ROWAN-SOM Acute Myocardial Infarction Definition:

More information

Acute Coronary Syndrome

Acute Coronary Syndrome Acute Coronary Syndrome Clinical Manifestation of CAD Silent Ischemia/asymptomatic Stable Angina Acute Coronary Syndrome (Non- STEMI/UA and STEMI) Arrhythmias Heart Failure Sudden Death Pain patterns with

More information

Ventricular Tachycardia Associated Syncope in a Patient of Variant Angina without Chest Pain

Ventricular Tachycardia Associated Syncope in a Patient of Variant Angina without Chest Pain Case Report Print ISSN 1738-5520 On-line ISSN 1738-5555 Korean Circulation Journal Ventricular Tachycardia Associated Syncope in a Patient of Variant Angina without Chest Pain Soo Jin Kim, MD, Ji Young

More information

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None

Disclosures. Inpatient Management of Non-ST Elevation Acute Coronary Syndromes. Edward McNulty MD, FACC. None Inpatient Management of Non-ST Elevation Acute Coronary Syndromes Edward McNulty MD, FACC Assistant Clinical Professor UCSF Director, SF VAMC Cardiac Catheterization Laboratory Disclosures None New Guidelines

More information

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor

What oral antiplatelet therapy would you choose? a) ASA alone b) ASA + Clopidogrel c) ASA + Prasugrel d) ASA + Ticagrelor 76 year old female Prior Hypertension, Hyperlipidemia, Smoking On Hydrochlorothiazide, Atorvastatin New onset chest discomfort; 2 episodes in past 24 hours Heart rate 122/min; BP 170/92 mm Hg, Killip Class

More information

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20. Journal of the American College of Cardiology Vol. 35, No. 4, 2000 2000 by the American College of Cardiology ISSN 0735-1097/00/$20.00 Published by Elsevier Science Inc. PII S0735-1097(99)00643-9 Early

More information

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine

Exercise Test: Practice and Interpretation. Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine Exercise Test: Practice and Interpretation Jidong Sung Division of Cardiology Samsung Medical Center Sungkyunkwan University School of Medicine 2 Aerobic capacity and survival Circulation 117:614, 2008

More information

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS Table of Contents List of authors pag 2 Supplemental figure I pag 3 Supplemental figure II pag 4 Supplemental

More information

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome

Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Relationship between body mass index, coronary disease extension and clinical outcomes in patients with acute coronary syndrome Helder Dores, Luís Bronze Carvalho, Ingrid Rosário, Sílvio Leal, Maria João

More information

Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy

Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy Case Report Acta Cardiol Sin 2013;29:462 466 Recurrent Thrombosis in a Case of Coronary Ectasia with Large Thrombus Burden Successfully Treated by Adjunctive Warfarin Therapy Hung-Hao Lee, 1 Tsung-Hsien

More information

A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES

A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES A CASE REPORT AND LITERATURE REVIEW ON MYOCARDIAL INFARCTION WITH NORMAL CORONARY ARTERIES Niyamtullah Musalman 1*, Lijun Jin 2 and Farhan Khan 3 *12 Department of Cardiology, Yangtze Medical University

More information

Continuing Medical Education Post-Test

Continuing Medical Education Post-Test Continuing Medical Education Post-Test Based on the information presented in this monograph, please choose one correct response for each of the following questions or statements. Record your answers on

More information

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia

P F = R. Disorder of the Breast. Approach to the Patient with Chest Pain. Typical Characteristics of Angina Pectoris. Myocardial Ischemia Disorder of the Breast Approach to the Patient with Chest Pain Anthony J. Minisi, MD Department of Internal Medicine, Division of Cardiology Virginia Commonwealth University School of Medicine William

More information

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute

ECG in coronary artery disease. By Sura Boonrat Central Chest Institute ECG in coronary artery disease By Sura Boonrat Central Chest Institute EKG P wave = Atrium activation PR interval QRS = Ventricle activation T wave= repolarization J-point EKG QT interval Abnormal repolarization

More information

Cho et al., 2009 Journal of Cardiology (2009), 54:

Cho et al., 2009 Journal of Cardiology (2009), 54: Endothelial Dysfunction, Increased Carotid Artery Intima-media Thickness and Pulse Wave Velocity, and Increased Level of Inflammatory Markers are Associated with Variant Angina Cho et al., 2009 Journal

More information

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003

Cardiovascular Health Practice Guideline Outpatient Management of Coronary Artery Disease 2003 Authorized By: Medical Management Guideline Committee Approval Date: 12/13/01 Revision Date: 12/11/03 Beta-Blockers Nitrates Calcium Channel Blockers MEDICATIONS Indicated in post-mi, unstable angina,

More information

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United

Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United Heart disease remains the leading cause of morbidity and mortality in industrialized nations. It accounts for nearly 40% of all deaths in the United States, totaling about 750,000 individuals annually

More information

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension

Hospital and 1-year outcome after acute myocardial infarction in patients with diabetes mellitus and hypertension (2003) 17, 665 670 & 2003 Nature Publishing Group All rights reserved 0950-9240/03 $25.00 www.nature.com/jhh ORIGINAL ARTICLE Hospital and 1-year outcome after acute myocardial infarction in patients with

More information

Journal of the American College of Cardiology Vol. 39, No. 10, by the American College of Cardiology Foundation ISSN /02/$22.

Journal of the American College of Cardiology Vol. 39, No. 10, by the American College of Cardiology Foundation ISSN /02/$22. Journal of the American College of Cardiology Vol. 39, No. 10, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01841-7

More information

Prehospital and Hospital Care of Acute Coronary Syndrome

Prehospital and Hospital Care of Acute Coronary Syndrome Ischemic Heart Diseases Prehospital and Hospital Care of Acute Coronary Syndrome JMAJ 46(8): 339 346, 2003 Katsuo KANMATSUSE* and Ikuyoshi WATANABE** * Professor, Second Internal Medicine, Nihon University,

More information

Acute Myocardial Infarction. Willis E. Godin D.O., FACC

Acute Myocardial Infarction. Willis E. Godin D.O., FACC Acute Myocardial Infarction Willis E. Godin D.O., FACC Acute Myocardial Infarction Definition: Decreased delivery of oxygen and nutrients to the myocardium Myocardial tissue necrosis causing irreparable

More information

Ambulatory Care Conference

Ambulatory Care Conference Ambulatory Care Conference David Stultz, MD August 28, 2002 Case Presentation 50 year old white female presents to ED with substernal chest pain. Pain started while driving, is left substernal in location

More information

Acetylcholine coronary spasm provocation testing: Revaluation in the real clinical practice

Acetylcholine coronary spasm provocation testing: Revaluation in the real clinical practice Research article Interventional Cardiology Acetylcholine coronary spasm provocation testing: Revaluation in the real clinical practice Background: Japanese Circulation Society guidelines for coronary spastic

More information

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh

Stress ECG is still Viable in Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG is still Viable in 2016 Suleiman M Kharabsheh, MD, FACC Consultant Invasive Cardiologist KFHI KFSHRC-Riyadh Stress ECG Do we still need stress ECG with all the advances we have in the CV field?

More information

LEFT MAIN DISEASE PATIENT PROFILE

LEFT MAIN DISEASE PATIENT PROFILE LEFT MAIN DISEASE PATIENT PROFILE MUHAMMAD YOUSUF SHAIKH*, MANSOOR AHMAD*, A RASHEED*, DAD M. JAN*, MANSOOR ALI* Background: Left main coronary artery (LMCA) disease is a potentially lethal disease that

More information

12 Lead ECG Workshop. Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA. California Association of Nurse Practitioners March 18, 2016

12 Lead ECG Workshop. Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA. California Association of Nurse Practitioners March 18, 2016 12 Lead ECG Workshop Virginia Hass, DNP, FNP-C, PA-C Kim Newlin, CNS, ANP-C, FPCNA California Association of Nurse Practitioners March 18, 2016 Learning Objectives Identify key changes on the ECG which

More information

Team members: Felix Krainski, Besiana Liti, William Lane Duvall (ASNC member)

Team members: Felix Krainski, Besiana Liti, William Lane Duvall (ASNC member) ASNC Choosing Wisely Challenge 2016 An outpatient pathway for chest pain visits to the emergency department reduces length of stay, radiation exposure, and is patient-centered, safe and cost-effective.

More information

Abstract Background: Methods: Results: Conclusions:

Abstract Background: Methods: Results: Conclusions: Two-Year Clinical and Angiographic Outcomes of Overlapping Sirolimusversus Paclitaxel- Eluting Stents in the Treatment of Diffuse Long Coronary Lesions Kang-Yin Chen 1,2, Seung-Woon Rha 1, Yong-Jian Li

More information

Prolonged Oral Morphine Therapy for Severe Angina Pectoris

Prolonged Oral Morphine Therapy for Severe Angina Pectoris Vol. 19 No. 5 May 2000 Journal of Pain and Symptom Management 393 Clinical Note Prolonged Oral Morphine Therapy for Severe Angina Pectoris Meir Mouallem, MD, Eli Schwartz, MD, and Zvi Farfel, MD Department

More information

Acute Myocardial Infarction: Difference in the Treatment between Men and Women

Acute Myocardial Infarction: Difference in the Treatment between Men and Women Quality Assurance in Hcahh Can, Vol. 5, No. 3, pp. 261-265,1993 Printed in Great Britain 1040-6166/93 $6.00 + 0.00 1993 Pergamon Press Ltd Acute Myocardial Infarction: Difference in the Treatment between

More information

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18

UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME. DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 UPDATE ON THE MANAGEMENTACUTE CORONARY SYNDROME DR JULES KABAHIZI, Psc (Rwa) Lt Col CHIEF CONSULTANT RMH/KFH 28 JUNE18 INTRODUCTION The clinical entities that comprise acute coronary syndromes (ACS)-ST-segment

More information

CORONARY ARTERY DISEASES

CORONARY ARTERY DISEASES CORONARY ARTERY DISEASES It has been estimated that over one third of the population eventually will die of CAD, and 20% will develop symptoms when younger than age 60 years. ANATOMY OF THE CORONARY ARTERIES

More information

Treatment Options for Angina

Treatment Options for Angina Treatment Options for Angina Interventional Cardiology Perspective Michael A. Robertson, M.D. 10/30/10 Prevalence of CAD in USA 15 million Americans with CAD 2 million diagnostic catheterizations 1 million

More information

ijcrr A DIFFUSE CORONARY SPASM A VARIANT OF A VARIANT?

ijcrr A DIFFUSE CORONARY SPASM A VARIANT OF A VARIANT? A DIFFUSE CORONARY SPASM A VARIANT OF A VARIANT? A.Noel, B. Amirthaganesh ijcrr Vol 04 issue 01 Category: Case Report Received on:19/10/11 Revised on:24/10/11 Accepted on:28/10/11 Department of Cardiology,

More information

egfr > 50 (n = 13,916)

egfr > 50 (n = 13,916) Saxagliptin and Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus and Moderate or Severe Renal Impairment: Observations from the SAVOR-TIMI 53 Trial Supplementary Table 1. Characteristics according

More information

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions

ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Julinda Mehilli, MD Deutsches Herzzentrum Technische Universität Munich Germany ISAR-LEFT MAIN: A Randomized Clinical Trial on Drug-Eluting Stents for Unprotected Left Main Lesions Background Left main

More information

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.

Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure. Coral Trials: A personal experience that challenges its results in patients with uncontrolled blood pressure.. Dr. Javier Ruiz Aburto, FACS, FICS Assistant Professor Ponce School of Medicine Puerto Rico

More information

JMSCR Vol 07 Issue 01 Page January 2018

JMSCR Vol 07 Issue 01 Page January 2018 www.jmscr.igmpublication.org Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v7i1.109 Short Term Outcome in a Severe Coronary Artery Disease with

More information

The MAIN-COMPARE Study

The MAIN-COMPARE Study Long-Term Outcomes of Coronary Stent Implantation versus Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Disease Revascularization for Unprotected Left MAIN Coronary Artery Stenosis:

More information

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20.

Journal of the American College of Cardiology Vol. 37, No. 2, by the American College of Cardiology ISSN /01/$20. Journal of the American College of Cardiology Vol. 37, No. 2, 2001 2001 by the American College of Cardiology ISSN 0735-1097/01/$20.00 Published by Elsevier Science Inc. PII S0735-1097(00)01133-5 Coronary

More information

MYOCARDIALINFARCTION. By: Kendra Fischer

MYOCARDIALINFARCTION. By: Kendra Fischer MYOCARDIALINFARCTION By: Kendra Fischer Outline Definition Epidemiology Clinical Aspects Treatment Effects of Exercise Exercise Testing Exercise Rx Summary and Conclusions References Break it down MYOCARDIAL

More information

An Open Randomized Study Prague-5 ˆ

An Open Randomized Study Prague-5 ˆ Next Day Discharge After Successful Primary Angioplasty for Acute ST Elevation Myocardial Infarction An Open Randomized Study Prague-5 Radovan JIRMÁR, 1 MD, Petr WIDIMSKÝ, 1 MD, Jan CAPEK, 1 MD, Ota HLINOMAZ,

More information

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN

DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN DIFFERENTIATING THE PATIENT WITH UNDIFFERENTIATED CHEST PAIN Objectives Gain competence in evaluating chest pain Recognize features of moderate risk unstable angina Review initial management of UA and

More information

Coronary Plaque Sealing: The DEFER Study and more...

Coronary Plaque Sealing: The DEFER Study and more... Coronary Plaque Sealing: The DEFER Study and more... How Waiting Can Be Beneficial in Stable Coronary Artery Disease Patients ESC, Stockholm, 2005 M. Romanens, 21.09.2005 at www.kardiolab.ch DEFER Study:

More information

Ischemic heart disease

Ischemic heart disease Ischemic heart disease Introduction In > 90% of cases: the cause is: reduced coronary blood flow secondary to: obstructive atherosclerotic vascular disease so most of the time it is called: coronary artery

More information

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose

DECLARATION OF CONFLICT OF INTEREST. Nothing to disclose DECLARATION OF CONFLICT OF INTEREST Nothing to disclose Prognostic value of multidetector computed tomography coronary angiography in a large population of patients with unknown cardiac disease but suspected

More information

Maria Angela S. Cruz-Anacleto, MD

Maria Angela S. Cruz-Anacleto, MD Maria Angela S. Cruz-Anacleto, MD 57/Female Menopausal Non-HTN, non-dm Hypothyroid (s/p RAI 1997) Levothyroxine 100 ug OD 5 Months PTA Chest discomfort Stress Echocardiography 5 Months PTA Chest discomfort

More information

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI

DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, G. PAPANIKOLAOU GH, THESSALONIKI The Impact of AF on Natural History of CAD DR ALEXIA STAVRATI CARDIOLOGIST, DIRECTOR OF CARDIOLOGY DEPT, "G. PAPANIKOLAOU" GH, THESSALONIKI CAD MOST COMMON CARDIOVASCULAR DISEASE MOST COMMON CAUSE OF DEATH

More information

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University

Role of Clopidogrel in Acute Coronary Syndromes. Hossam Kandil,, MD. Professor of Cardiology Cairo University Role of Clopidogrel in Acute Coronary Syndromes Hossam Kandil,, MD Professor of Cardiology Cairo University ACS Treatment Strategies Reperfusion/Revascularization Therapy Thrombolysis PCI (with/ without

More information

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Percutaneous Coronary Interventions Without On-site Cardiac Surgery Percutaneous Coronary Interventions Without On-site Cardiac Surgery Hassan Al Zammar, MD,FESC Consultant & Interventional Cardiologist Head of Cardiology Department European Gaza Hospital Palestine European

More information

Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction

Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction Case Reports Coronary Spasm as a Cause of Coronary Thrombosis and Myocardial Infarction Masashi HORIMOTO, M.D., Takashi TAKENAKA, M.D., Keiichi IGARASHI, M.D. Masafumi FUJIWARA, M.D., and Sanjay BATRA,

More information

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018

Management of Stable Ischemic Heart Disease. Vinay Madan MD February 10, 2018 Management of Stable Ischemic Heart Disease Vinay Madan MD February 10, 2018 1 Disclosure No financial disclosure. 2 Overview of SIHD Diagnosis Outline of talk Functional vs. Anatomic assessment Management

More information

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW

PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW PERIOPERATIVE MYOCARDIAL INFARCTION THE ANAESTHESIOLOGIST'S VIEW Bruce Biccard Perioperative Research Group, Department of Anaesthetics 18 June 2015 Disclosure Research funding received Medical Research

More information

Acute coronary syndrome (ACS) is a potentially

Acute coronary syndrome (ACS) is a potentially DIAGNOSING ACUTE CORONARY SYNDROME AND DETERMINING PATIENT RISK Edith A. Nutescu, PharmD* ABSTRACT Acute coronary syndrome is a form of coronary artery disease and has a broad range of clinical presentations.

More information

The prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction

The prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction The prognostic role of serum uric acid level in patients with acute ST elevation myocardial infarction Bita Omidvar a, Fazlolah Ayatollahi a, Mohammad Alasti b, a Department of Internal Medicine, Golestan

More information

Listing Form: Heart or Cardiovascular Impairments. Medical Provider:

Listing Form: Heart or Cardiovascular Impairments. Medical Provider: Listing Form: Heart or Cardiovascular Impairments Medical Provider: Printed Name Signature Patient Name: Patient DOB: Patient SS#: Date: Dear Provider: Please indicate whether your patient s condition

More information

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI

TCTAP Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Indian TUXEDO Trial In Medically Treated Diabetics Upendra Kaul MD,DM,FACC,FSCAI,FAMS,FCSI Executive Director and Dean Escorts Heart Institute & Medical Research Center and Fortis Hospitals, New Delhi

More information

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1.

Supplementary material 1. Definitions of study endpoints (extracted from the Endpoint Validation Committee Charter) 1. Rationale, design, and baseline characteristics of the SIGNIFY trial: a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease without clinical

More information

(For items 1-12, each question specifies mark one or mark all that apply.)

(For items 1-12, each question specifies mark one or mark all that apply.) Form 121 - Report of Cardiovascular Outcome Ver. 9.2 COMMENTS -Affix label here- Member ID: - - To be completed by Physician Adjudicator Date Completed: - - (M/D/Y) Adjudicator Code: - Central Case No.:

More information